The most common cardiovascular side effects of antidepressants are cardiac
arrhythmias and orthostatic hypotension. Little is known, however, about th
e mechanisms by which these adverse reactions may occur, especially with re
gard to newer drugs such as fluoxetine. We hypothesized that these side eff
ects may have an electrophysiological basis at the level of the cardiac myo
cyte. Thus, we investigated the effects of fluoxetine and other antidepress
ants on action potentials and ionic currents of rat ventricular myocytes us
ing the amphotericin B perforated patch clamp technique. Fluoxetine (10 mu
M) prolonged the action potential duration (APD(50)) to 146.7 +/- 12.9% of
control value without altering resting membrane potential. Fluoxetine and s
ettraline potently inhibited the L-type Ca2+ current (IC50, = 2.82 and 2.31
mu M, respectively), but did not significantly modify the steady-state ina
ctivation. Amitriptyline and imipramine had similar, but slightly weaker, e
ffects (IC50 = 3.75 and 4.05 mu M, respectively). Fluoxetine attenuated the
peak transient outward K+ current and also altered current kinetics, as sh
own by accelerated decay. Fluoxetine did not change the voltage-dependence
of the steady-state inactivation. Sertraline, amitriptyline and imipramine
inhibited the transient outward K+ current with potencies very similar to f
luoxetine. In contrast to the other antidepressants tested, trazodone weakl
y inhibited the Ca2+ and K+ currents and moclobemide had no detectable effe
ct. Our comparative pharmacology data suggest that selective serotonin reup
take inhibitors, such as fluoxetine, are as potent as tricyclic antidepress
ants in inhibiting L-type Ca2+ and transient outward K+ currents. These inh
ibitory effects may contribute to cardiovascular complications such as arrh
ythmias and orthostatic hypotension.